Effects of Targets of Blood Pressure on Cerebral Hemodynamics in Septic Shock

Sponsor
D'Or Institute for Research and Education (Other)
Overall Status
Recruiting
CT.gov ID
NCT05833607
Collaborator
(none)
40
1
24
1.7

Study Details

Study Description

Brief Summary

The sudy objective is to evaluate the cerebral haemodynamic status in different ranges of systemic arterial pressure in patients with septic shock by noninvasive tools, transcranial doppler and intracranial compliance by mechanical sensor (B4C).

Patients participating in the study will be submitted to different levels of arterial pressure, titrated with vasopressor and them their cerebral hemodynamic variables will be evaluated,

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Sepsis is the most prevalent cause of admissions to the intensive care unit (ICU) and many of these patients develop septic shock (SC) (need for vasoactive drug, after adequate fluid administration, plus hyperlactatemia). The SC involvement is systemic, so the investigators started to monitor organ dysfunctions and their perfusion windows, including neurological disorders, when is affected, in addition to indicating severity, are also a predictor of worse prognosis.

    The principle of cerebral autoregulation (CA) is the basic defense mechanism against pressure oscillations in the most diverse contexts. The SC is a state of vasodilation and consequent drop in mean arterial pressure (MAP), that under normal physiological conditions would be compensated by CA. But it is not known exactly how CA performance at this profile of patients.

    The investigators will assess cerebral hemodynamics in SC patients at different MAP targets, in order to identify whether this regulatory variable would be able to generate better parameters of cerebral hemodynamics.

    Some smaller studies have shown that liver and heart dysfunction correlate with worsening autoregulation. Another clinical trial showed an inverse relationship between CA and the Sequential Organ Failure Assessment, in addition to the loss of CA in patients with circulatory shock in general. Post-mortem data found generalized ischemic lesions in the brain of septic patients, which translates into a state of reduction at vascular flow. This patient profile has more blood-brain barrier dysfunction, but further studies are needed to correlate CA and CS.

    The study will be carried out in the ICU of Hospital São Rafael (HSR), located in the city of Salvador-Ba, Brazil. For the evaluation of cerebral hemodynamics Transcranial Doppler and a Mechanical sensor (B4C) will be used.

    Data collection on admission will include the following: demographic characteristics, comorbidities, source of infection, Sequential Organ Failure Assessment (SOFA) at ICU admission, temperature, Glasgow Coma scale (GCE) or Richmond Agitation Sedation Scale (RASS), mechanical ventilation, arterial blood gasses before and after the protocol.

    All patients will be monitored with an arterial line, cardioscopy, pulse oximetry and capnography (if unavailable at the time of collection, this will be described). Before starting the monitoring, the proper functioning of the arterial circuit will be confirmed and a blood gas analysis will be collected, as well as at the end.

    The investigators will collet data with the patient's baseline pressure for 5 minutes (T0), then through the titration of vasopressors, for another 5 minutes each mean arterial pressure target at 65mmHg (T1), 75 mmHg (T2) and 85 mmHg (T3). After collection, the baseline mean arterial pressure will be restored

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    40 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Effects of Systemic Blood Pressure Targets on Cerebral Hemodynamics in Septic Shock: a Prospective Study
    Actual Study Start Date :
    Jul 7, 2022
    Anticipated Primary Completion Date :
    Dec 30, 2023
    Anticipated Study Completion Date :
    Jul 7, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    ALL PATIENTS

    All patients are monitored with the transcranial Doppler helmet and the 2Hz probe in one of the middle cerebral hemispheres and the Brain 4 care on the other side. Necessary monitoring: arterial line, electrocardiographic monitor, pulse oximetry, temperature. ETCO2 monitoring whenever possible. Step 1: Test arterial line circuit, ensure proper temperature, arterial blood gases Step 2: Record data with the patient's baseline pressure (data from the monitor, transcranial doppler and brain4care), for 5 min Step 3: Vasopressor titrant for 3 MAP targets (65, 75 and 85 mmHg) , record data with the patient's baseline pressure (data from the monitor, transcranial doppler and brain4care), each target record for 3 minutes Step 4: Arterial blood gases, gradually restore PAM to baseline value

    Outcome Measures

    Primary Outcome Measures

    1. The primary objective is to evaluate the effects of cerebral haemodynamic in patients with septic shock in different targets of MAP, through ARI (by Transcranial Doppler), and intracranial compliance by mechanical sensor (B4C) [Data will be obtained at the time of collection (mean arterial pressure targets) and subsequently analyzed]

      This outcome will be analyzed by transcranial Doppler (ARI, PI) and B4C (intracranial compliance) index). Data will be obtained at the time of collection (mean arterial pressure targets) and subsequently analyzed

    Secondary Outcome Measures

    1. Assess factors that influence cerebral autoregulation (by ARI) and intracranial compliance (B4C) [Data will be obtained at the time of collection (mean arterial pressure targets) and subsequently analyzed]

      To verify clinical factors that influence cerebral autoregulation (CA) and intracranial compliance of septic patients

    2. Evaluate the correlation between CA by TDC and B4C index. [Data will be obtained at the time of collection (mean arterial pressure targets) and subsequently analyzed]

      Report the similarity between the two indices

    3. Correlate mechanical ventilation time with perfusion pressure value [Mechanical ventilation time up to 28 days]

      Observation that there is a correlation between the duration of mechanical ventilation and the patient's baseline perfusion pressure

    4. Explore the correlation between incidence of brain dysfunction [Until 28º day]

      Brain dysfunction will be considered as: Glasgow Coma Scale score < 15 or when disorientation, altered thinking or agitation was reported by the attending physician, independently of the use of sedatives/analgesics and in the absence of previous neurological diseases (i.e., dementia, cerebrovascular disease, brain tumors, previous traumatic brain injury) with DTC and B4C index.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • < 48 hours in the intensive care unit

    • Septic shock (sepsis 3.0)

    Exclusion Criteria:
    • No window for DTC

    • Hepatic or uremic encephalopathy

    • Pregnancy

    • Acute or prior structural neurological insult

    • Exogenous intoxication

    • Dementia

    • Chronic Obstructive Pulmonary Disease

    • Instability for acute arrhythmia

    • Extracorporeal support by modifying the pulse wave form (intra aortic balloon pump and Extracorporeal membrane oxygenation

    • Extreme severity, with imminent risk of death

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 São Rafael Hospital Salvador Bahia Brazil 41253-190

    Sponsors and Collaborators

    • D'Or Institute for Research and Education

    Investigators

    • Principal Investigator: Juliana Caldas, Phd, D'Or Institute for Research and Education (IDOR), Hospital São Rafael
    • Study Chair: Pedro Cury, D'Or Institute for Research and Education (IDOR), Hospital São Rafael

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    D'Or Institute for Research and Education
    ClinicalTrials.gov Identifier:
    NCT05833607
    Other Study ID Numbers:
    • 28134720.1.0000.0048
    First Posted:
    Apr 27, 2023
    Last Update Posted:
    Apr 27, 2023
    Last Verified:
    Apr 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by D'Or Institute for Research and Education
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 27, 2023